James Lapworth

CBO at Myeloid Therapeutics

Speaker

James is an experienced business development and venture-building professional with over 15 years' experience in fundraising, developing, partnering and out-licensing new technologies, particularly in the drug discovery and biotech sectors.

As part of the founding team at NanoSyrinx, he has played a leading role in raising equity finance (>$20M to date), developing corporate strategy and driving BD, IP & operational functions within the company.